Independent clinical trials [11]

Lancet

Volumn 363, Issue 9414, 2004, Pages 1080-

  Maggio, Aurelio ^a   D'Amico, Gennaro ^a   Morabito, Alberto ^b  

^a VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^b SAN PAOLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DEFERIPRONE; DEFEROXAMINE;

CLINICAL RESEARCH; CLINICAL TRIAL; DRUG INDUSTRY; DRUG RESEARCH; FINANCIAL MANAGEMENT; HUMAN; LETTER; PRIORITY JOURNAL; SICKLE CELL ANEMIA; THALASSEMIA MAJOR;

EID: 1642603887     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)15863-7     Document Type: Letter

References (5)

1. Maggio A., D'Amico G., Morabito A., et al. Deferiprone versus deferoxamine in patients with thalassemia major: a randomized clinical trial. Blood Cell Mol Dis. 28:2002;196-208.
2. Constantinou G., Melides S., Modell B., et al. The Olivieri case. N Engl J Med. 348:2003;860-863.
3. Rosoff P.M. Industrial collaboration. N Engl J Med. 348:2003;863.
4. Kiln M.R., Hirst JMD. Academia and industry. Lancet. 356:2000;1359.
5. Sulston J. Beyond release: the equitable use of genomic information. Lancet. 362:2003;400-402.